Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. - Wikidata - wikimedia - TriplyDB

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q34629550

about

Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems Epigenetic regulation in cardiac fibrosis MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis Myosin binding protein C: implications for signal-transduction Genetic considerations in hypertrophic cardiomyopathy Research priorities in sarcomeric cardiomyopathies Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy Thin filament mutations: developing an integrative approach to a complex disorder Genetics of sudden cardiac death syndromes Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational study The role of imaging in hypertensive heart disease The role of magnetic resonance imaging in hypertrophic cardiomyopathy.Localised micro-mechanical stiffening in the ageing aorta.Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function.Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.Echocardiography and cardiac MRI in mutation-negative hypertrophic cardiomyopathy in an older patient: a case defining the need for ICD.Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.Matrix elasticity regulates the optimal cardiac myocyte shape for contractility.The systolic paradox in hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats.Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: a heart in need of an energy bar?Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines.Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor.Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model.Determining the role of fibrosis in hypertrophic cardiomyopathy.Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus.Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.

P2860

Q26744762-13355B4B-7C6E-407C-AA5C-DE5383014BA5 Q26774536-B8055608-1E88-4CF8-A7B4-068597BB7193 Q26778555-97FC7579-64D4-4175-9BED-9DC3EEC01B77 Q26824231-9E7A91A5-1004-4D46-8B88-D99F346F3B13 Q26864740-A09C96EF-D373-4121-A8D2-B9BC5A41A48C Q26865973-3EF33C58-4EA6-4537-ABD0-B73286E5CA4C Q27025791-483A7696-FD6E-4EEE-8F12-BD28F2226A6A Q27694507-9C8D560E-0BD9-4653-98FC-AC6F468E5A37 Q28075470-5AF6B912-13B8-41D1-89C7-2CAD08DC4000 Q28307606-7378DC67-F75C-4A82-A4BC-003933BEB975 Q28307856-7A36CB64-6633-40C6-B232-B9D716EF5A01 Q28730121-DABABB49-9334-4B75-90A7-DBBDE0A39401 Q30278822-4C690DA8-1FC4-4A7F-A4F7-B39931C10E74 Q30371882-B840EE09-F152-46BB-BBDE-69E2C6C3C099 Q30408445-19A99684-1707-41F8-9DD0-183A64D69125 Q30410260-A26B54EB-D967-494C-AEA7-7700EAD46CB4 Q30426380-B9F97BD9-9A48-4B0D-9487-99173E49D2F5 Q30473383-8A2BFDE9-EE4B-42D6-A4D0-28558ED3716F Q30513942-E85587B5-AF69-4EA1-81CC-50E357851F26 Q33162387-B272DAF0-8573-41B2-8ED6-86C18C36F364 Q33164286-5961C6D8-2455-491C-9C17-9AF1D1CDD6F3 Q33166450-AB4587CD-DADC-4090-8C8F-C545E3DDC6E9 Q33554999-34192EF7-7189-46EA-9DC7-7C64934B7FA4 Q33574837-5D5C1D11-2FC8-464E-AA80-53D80D52DA66 Q33634302-6CFCC0D2-2E54-4168-8731-1DE5BD4579D9 Q33701944-09BCC7C7-EA44-4A34-8F5B-E4D3465A419D Q33801809-31994948-4462-4E79-97B0-2616298B3544 Q33969167-754DB203-0F29-421E-BD83-0E92D6131E45 Q33991604-241AEF2A-FA98-488B-B32B-2B0D013D5F67 Q34014152-53FDA3A9-D8A3-47AD-8961-AB62DC5A553C Q34063733-9F646CD1-9D52-4C5E-944E-E00EAD9F5D9D Q34178860-80D2A935-42EC-49BC-8434-353F82FE41D6 Q34181672-132AF15C-4F70-480B-9137-FED835EA4C4A Q34219487-F9CEEBBE-163C-4580-B6EF-66A532ED75AF Q34486554-B345DBB3-B24E-4FE6-AA44-235CEDC2CE83 Q34660599-32DD1D4B-D95C-4196-A8F1-ED85DB07E225 Q34686973-92D3A3A7-1FD3-4C96-8475-A1FB2DD22866 Q34734901-3A78E3C5-D175-414A-8108-ECC4DF459033 Q34999606-E6F63CD1-6A87-45C3-B748-6ECB2E8199CF Q35065245-126720BB-B1A4-4610-A289-498AF4C64B96

P2860

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q34629550

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@ast

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@en

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@nl

type

label

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@ast

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@en

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@nl

prefLabel

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@ast

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@en

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@nl

P1433

Q34629550-B808282F-5CCB-4BD7-B776-366C3CC1BF50

P1476

Q34629550-B3639179-1021-4B79-AA43-082BE645883B

P2093

Q34629550-0ADB5DA0-BE1F-4D47-95CE-34FDA0F25E37

Q34629550-1B7EEA9C-4ED4-42D3-AC4A-39A6437E8EE2

Q34629550-2864D12A-7B27-46F4-BEB3-04278917F0DE

Q34629550-2D110C31-37DE-4770-B025-225C0F3C645C

Q34629550-349C208C-14D3-4F6A-A807-23A2591C4EC1

Q34629550-48FC017B-C66E-4102-8320-ACFC4BD1436B

Q34629550-49DFCE0B-4B9E-4290-A573-0DFBB0A2F638

Q34629550-52583D4D-D20A-49F6-8DDD-D65A9DBB9DDA

Q34629550-58FB4FB1-9F83-4F78-B52A-F99947A130BF

Q34629550-BF31E710-BBFE-4DE5-A486-AD3CA0900633

P2860

Q34629550-0D5CC0EA-47BD-4FDE-93E4-F4E14BB2B05E

Q34629550-10272D6D-81CE-411C-A783-63391E77E797

Q34629550-21DBE403-E4A7-4A16-8274-6D55EC3B2065

Q34629550-33A13982-9932-4DE7-8EA9-72FCCB3D21F5

Q34629550-362DBDB1-BA85-479F-AD42-39F26BBAAC90

Q34629550-36633882-5120-4062-91BE-F8DAFFC93D1E

Q34629550-3E37D9DB-1E06-4896-903F-14DAB1506E16

Q34629550-44B1287F-7CB5-4C1D-B833-CB8A2270A57A

Q34629550-53AC9FAE-7057-4F75-AAA3-D0AA161D8F02

Q34629550-59B37DBF-61B6-4B01-BD07-750270AE515E

P304

Q34629550-5E5CC96C-4A40-4DA8-B896-F451C480E311

P31

Q34629550-3AAD61A4-DAB5-4727-925E-1BF71F9460BD

P356

Q34629550-AFC775D9-5D23-4965-B44E-AEB328341EED

P407

Q34629550-B92F1111-DE2E-4234-B47B-5E07EAE7B8C7

P433

Q34629550-6A681EDC-AC6F-432E-AEA3-81CC1E5F146E

P478

Q34629550-B7D156F6-1972-4099-AB5B-BEF12697B135

P50

Q34629550-4004E32C-B19B-4F77-9976-F57010672270

Q34629550-B50774D8-6879-4980-81D3-FB565238BD0D

P577

Q34629550-B0019EB2-617C-4471-A77F-3269F1379319

P698

Q34629550-0582B906-A2AE-445F-B37E-D32E58FE00DF

P932

Q34629550-05CA8BA3-350B-4939-9240-06D389E60028

P356

P1433

The New England Journal of Medicine

P1476

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.

@en

P2093

Allison L Cirino

http://www.w3.org/2001/XMLSchema#string

Arantxa González

http://www.w3.org/2001/XMLSchema#string

Christine E Seidman

http://www.w3.org/2001/XMLSchema#string

J G Seidman

http://www.w3.org/2001/XMLSchema#string

Javier Díez

http://www.w3.org/2001/XMLSchema#string

Neal K Lakdawala

http://www.w3.org/2001/XMLSchema#string

Otavio R Coelho-Filho

http://www.w3.org/2001/XMLSchema#string

Petr Jarolim

http://www.w3.org/2001/XMLSchema#string

Raymond Kwong

http://www.w3.org/2001/XMLSchema#string

Steven D Colan

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

A mouse model of familial hypertrophic cardiomyopathy

The Genetic Basis for Cardiomyopathy

Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy

Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.

Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy.

P304

552-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1002659

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

363

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20818890

http://www.w3.org/2001/XMLSchema#string

P932

3049917

http://www.w3.org/2001/XMLSchema#string